INTEST (INTT) director Maginnis receives 12,000-share stock grant

Rhea-AI Filing Summary

Maginnis Gerald J. reported acquisition or exercise transactions in this Form 4 filing.

INTEST CORP director Gerald J. Maginnis received an award of 12,000 shares of Common Stock on March 16, 2026. The grant carried a price of $0.0000 per share, indicating a share-based award rather than a market purchase. After this transaction, he directly holds 96,057 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maginnis Gerald J.

(Last) (First) (Middle)

C/O INTEST CORP

804 EAST GATE DR, SUITE 200

(Street)

MT. LAUREL NEW JERSEY 08054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTEST CORP [ INTT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		A		12,000	A	$0	96,057	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Duncan Gilmour, Attorney-in-Fact for Gerald J. Maginnis	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did INTT director Gerald J. Maginnis report?

Gerald J. Maginnis reported receiving an award of 12,000 INTEST CORP common shares. The Form 4 classifies this as a grant or other acquisition, reflecting additional equity compensation rather than an open-market trade in the company’s stock.

When did the reported INTT insider share award to Gerald J. Maginnis occur?

The share award to Gerald J. Maginnis occurred on March 16, 2026. On that date, he acquired 12,000 shares of INTEST CORP common stock as a grant, according to the Form 4 insider trading disclosure filed for the company.

How many INTT shares does Gerald J. Maginnis hold after this Form 4 transaction?

After the reported transaction, Gerald J. Maginnis directly holds 96,057 INTEST CORP common shares. This total includes the 12,000-share grant reported in the Form 4, showing his updated direct ownership position in the company’s stock following the award.

Was the INTT insider transaction by Gerald J. Maginnis a market buy or a grant?

The transaction was a grant, not a market buy. The Form 4 shows transaction code “A” and describes it as a grant, award, or other acquisition, with a price of $0.0000 per share, indicating share-based compensation rather than an open-market purchase.

What type of security did Gerald J. Maginnis receive in the INTT Form 4 filing?

He received INTEST CORP Common Stock according to the Form 4. The filing lists the security title as Common Stock and records an acquisition of 12,000 shares, increasing his direct holdings in this class of the company’s equity securities.

Does the INTT Form 4 for Gerald J. Maginnis involve derivative securities or only common stock?

The filing involves only common stock, with no derivative securities reported. The transaction section lists Common Stock as the security and the derivative summary section is empty, indicating no options, warrants, or other derivatives were part of this Form 4.